Junzhang Zhao
Overview
Explore the profile of Junzhang Zhao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
104
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang Q, Wang W, Xiang B, Lin D, Hu J, Zhao J, et al.
Gastroenterol Rep (Oxf)
. 2024 Nov;
12:goae103.
PMID: 39530074
Background: The genetic variant of tumor necrosis factor superfamily member 15 () is associated with Crohn's disease (CD) and the development of intestinal fibrosis and stricturing. We aimed to investigate...
2.
Yan J, Zeng Y, Guan Z, Li Z, Luo S, Niu J, et al.
Cell Rep
. 2024 Aug;
43(8):114636.
PMID: 39154340
Inflammatory bowel disease (IBD) has high prevalence in Western counties. The high fat content in Western diets is one of the leading causes for this prevalence; however, the underlying mechanisms...
3.
Wang W, Zhang Q, Zhao J, Liu T, Yao J, Peng X, et al.
Gastroenterol Rep (Oxf)
. 2024 Jul;
12:goae074.
PMID: 39055374
Background: The efficacy of anti-TNF therapy in Crohn's disease (CD), such as infliximab, is often compromised by the development of anti-drug antibodies (ADAs). The genetic variation HLA-DQA1*05 has been linked...
4.
Murthy D, Attri K, Suresh V, Rajacharya G, Valenzuela C, Thakur R, et al.
Proc Natl Acad Sci U S A
. 2024 Mar;
121(14):e2315509121.
PMID: 38547055
Dysregulation of polyamine metabolism has been implicated in cancer initiation and progression; however, the mechanism of polyamine dysregulation in cancer is not fully understood. In this study, we investigated the...
5.
Liu Y, Zhao J, Huang B, Liang Y, Jiang G, Zhou X, et al.
Biochim Biophys Acta Mol Cell Res
. 2024 Feb;
1871(4):119698.
PMID: 38387508
The integrated landscape of ferroptosis regulatory patterns and their association with colon microenvironment have been demonstrated in recent studies. However, the ferroptosis-related immunotherapeutic signature for colon cancer (CC) remains unclear....
6.
Zhong B, Xie W, Davis Kempton S, Zhi M, Zhao J
Health Commun
. 2023 Aug;
39(10):1978-1987.
PMID: 37635287
The affordances of social media, have significantly transformed how patients seek and process health information online, including those with chronic diseases like irritable bowel disease (IBD). Few studies have explored...
7.
Yao J, Peng X, Zhong Y, Su T, Bihi A, Zhao J, et al.
Front Med (Lausanne)
. 2023 Aug;
10:1105981.
PMID: 37554510
Objectives: Ustekinumab (UST) optimization strategies, including shortening intervals and intravenous reinduction, should be administered to patients with partial or loss of respond. Evidence comparing these types of optimization treatments is...
8.
Peng W, Yang J, Xia L, Qian X, Long G, Zhang H, et al.
Front Oncol
. 2023 Apr;
13:1178966.
PMID: 37064149
Introduction: Immunogenic cell death (ICD) is a sort of regulated cell death (RCD) sufficient to trigger an adaptive immunological response. According to the current findings, ICD has the capacity to...
9.
Yao J, Zhou J, Zhong Y, Zhang M, Peng X, Zhao J, et al.
Med Phys
. 2023 Apr;
50(6):3862-3872.
PMID: 37029097
Background: Identifying patients with aggressive Crohn's disease (CD) threatened by a high risk of early onset surgery is challenging. Purpose: We aimed to establish and validate a radiomics nomogram to...
10.
Yao J, Zhang H, Su T, Peng X, Zhao J, Liu T, et al.
J Clin Med
. 2023 Feb;
12(3).
PMID: 36769587
There is insufficient evidence to confirm the efficacy of ustekinumab (UST) in promoting fistula closure in perianal fistulizing Crohn's disease (CD) patients. We aimed to evaluate the efficacy of UST...